You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MDGL Exercise Disclosure
Sibold William John · SEC Form 4 · Filed Jul 20, 2026
Exercise
Calculated transaction value
$0
Sibold William John President And CEO
MDGL
Transaction date
Jul 17, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 3 days later
MDGL daily price context
Close on/before transaction
$553.48
Jul 17, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Performance Restricted Stock Units on Common Stock
- Quantity / price
- 50,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-048919
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.37M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $25.8K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $296.87K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $59.82K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $550.72 |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $147.16K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $372.43K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $84.15K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $75.98K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $155.41K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $150.07K |
| Madrigal Pharmaceuticals, Inc. MDGL Current | Exercise | Jul 17, 2026 | $0 |
| Madrigal Pharmaceuticals, Inc. MDGL | Exercise | Jul 17, 2026 | Not reported |